XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
  AIDS
  Influenza
  MRSA
  Tuberculosis
  Shigella
  HCV
  SARS
  Ebola
  Dengue
  Malaria
  Pertussis
  Mumps
  Prion Diseases
  Small Pox
  Anthrax
  Leishmaniasis
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Infectious Diseases Channel
subscribe to Infectious Diseases newsletter

Latest Research : Infectious Diseases

   DISCUSS   |   EMAIL   |   PRINT
Gauze developed with microbicidal coating
Sep 24, 2005, 15:28, Reviewed by: Dr.

"Gauze is still the most commonly used dressing for wounds. But the problem with gauze is when it absorbs fluid, it forms a great avenue for bacteria and fungus to grow. This treatment actually makes the gauze absorb a little more fluid, (but) it'll keep the wound cleaner because it will keep the bacteria from getting back into the wound."

 
University of Florida researchers have led the development of a new type of wound dressing that could keep dangerous antibiotic-resistant bacteria from spreading in hospitals, a problem that leads to thousands of deaths in the United States each year.

This microbicidal coating - which can be chemically bonded to gauze bandages, socks and even hospital bedding and gowns - kills the two most common and harmful types of antibiotic-resistant bacteria that cause infections in hospitals, the researchers said.

According to the National Institutes of Health, each year nearly 2 million Americans contract infections while hospitalized. Antibiotic-resistant bacteria, such as methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci, cause about 70 percent of those infections.

"Those are the two classes of bacteria that are now epidemic in the U.K.," said Gregory Schultz, Ph.D., director of UF's Institute for Wound Research and one of the inventors who joined with a Gainesville-based company to develop the coating. "It's a huge problem there."

A patent is pending on the researchers' method of chemically bonding the substance to fabrics and other materials. This method allows the substance to be efficiently mass produced and permanently adhered to wound dressings or ready-to-wear clothing to make antifungal and microbicidal socks and underwear.

Developed as the ultimate wound dressing, the coating blocks bacteria from reaching a wound and recolonizing there. UF researchers and scientists from the company presented their findings at the Wound Healing Society's annual meeting earlier this year, and the coating's ability to wipe out harmful bacteria and fungi was later confirmed in independent laboratory tests.

The coating also was designed to keep bacteria from becoming resistant to it. Popular silver dressings work well as a bacterial barrier but release ions that allow resistance to develop, Schultz said.

The structure of the microbicidal coating and the complexity of the process make it nearly impossible for bacteria to become resistant to it, Schultz said. The coating comprises thousands of nitrogen clusters that permanently bond to substances such as gauze and fabric. Other dressings use a process that allows molecules to diffuse into the air and into the wound, which can slow healing and increases the chance germs will develop resistance.

"These technologies are especially timely given the threats that are facing the American public, such as antibiotic-resistant bugs occurring in hospitals across the world," said Christopher Batich, Ph.D., a UF professor of biomedical engineering and one of the coating's inventors. When added to gauze, it makes the material superabsorbent, pulling excess moisture away from the sore. Bacteria in a wound "is like jet fuel for these bugs," Schultz said.

This treatment actually makes the gauze absorb a little more fluid, (but) it'll keep the wound cleaner because it will keep the bacteria from getting back into the wound."

Clinical trials of the coating in gauze will be conducted at UF later this year.

Controlling moisture and staving off infection are two of the most important aspects of wound healing, said Jeffrey M. Davidson, Ph.D., president of the Wound Healing Society and a Vanderbilt University professor of pathology.

"Bacteria will produce substances that are harmful to the cells around them.
 

- Clinical trials of the coating in gauze will be conducted at UF later this year.
 

www.ufl.edu

 
Subscribe to Infectious Diseases Newsletter
E-mail Address:

 



Related Infectious Diseases News

Keeping A3G in action represents a new way to attack HIV
Fighting HIV With HIV Virus Itself
Retina can provide a very reliable way of diagnosing cerebral malaria
Are influenza vaccines worth the effort?
A light daily exercise program may reduce the incidence of colds
HIV exploits competition among T-cells
Mass vaccination would not be necessary in the event of a smallpox bioterrorist attack
How Ebola and Marburg viruses cause disease
Transmission of MRSA Linked to Previous Intensive Care Unit Room Occupants
Harmless GB Virus type C (GBV-C) protects against HIV infection


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us